Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.
| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| Palisade Bio Inc. | LB1148 - (China trial) | Bowel Function Following Abdominal Surgery | Phase 3 | Trial Discontinued | Oral | Gastroenterology |
| Palisade Bio Inc. | LB1148 | Return of Postoperative Bowel Function Event | Phase 3 | Trial Discontinued | Oral | Gastroenterology |
| Palisade Bio Inc. | LB1148 | Gastrointestinal (GI) recovery in neonates | Phase 2/3 | Trial Discontinued | Oral | Gastroenterology |
| Palisade Bio Inc. | LB1148 | Improvement in bowel function following cardiovascular surgery | Phase 2 | Trial Discontinued | Oral | Gastroenterology |
| Palisade Bio Inc. | LB1148 - (PROFILE) | Reduction in adhesions following abdominal and pelvic surgery | Phase 2 | Trial Discontinued | Oral | Wound Care |
| Palisade Bio Inc. | LB1148 - (Dose Optimization) | Healthy volunteers | Phase 2 | Trial Discontinued | Oral | N/A |
| Palvella Therapeutics Inc. | QTORIN - (SELVA) | Microcystic lymphatic malformations (LMs) | Phase 3 | Ongoing | Topical | Genetic Disorder |
| Palvella Therapeutics Inc. | QTORIN pitavastatin | Disseminated superficial actinic porokeratosis (DSAP) | Phase 2 | Trial Planned | Topical | N/A |
